1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Liu S, Zheng R, Zhang M, Zhang S, Sun X
and Chen W: Incidence and mortality of colorectal cancer in China,
2011. Chin J Cancer Res. 27:22–28. 2015.PubMed/NCBI
|
4
|
Schreuders EH, Ruco A, Rabeneck L, Schoen
RE, Sung JJ, Young GP and Kuipers EJ: Colorectal cancer screening:
A global overview of existing programmes. Gut. 64:1637–1649. 2015.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of
p15INK4B tumor suppressor gene. Oncogene. 30:1956–1962.
2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Li W, Zhai L, Wang H, Liu C, Zhang J, Chen
W and Wei Q: Downregulation of LncRNA GAS5 causes trastuzumab
resistance in breast cancer. Oncotarget. 7:27778–27786.
2016.PubMed/NCBI
|
8
|
Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu
M and Mo YY: Long non-coding RNA UCA1 promotes breast tumor growth
by suppression of p27Kip1. Cell Death Dis. 5:e10082014.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhao Y, Guo Q, Chen J, Hu J, Wang S and
Sun Y: Role of long non-coding RNA HULC in cell proliferation,
apoptosis and tumor metastasis of gastric cancer: A clinical and
in vitro investigation. Oncol Rep. 31:358–364. 2014.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Chen X, Liu B, Yang R, Guo Y, Li F, Wang L
and Hu H: Integrated analysis of long non-coding RNAs in human
colorectal cancer. Oncotarget. 7:23897–23908. 2016.PubMed/NCBI
|
11
|
Yang L, Qiu M, Xu Y, Wang J, Zheng Y, Li
M, Xu L and Yin R: Upregulation of long non-coding RNA PRNCR1 in
colorectal cancer promotes cell proliferation and cell cycle
progression. Oncol Rep. 35:318–324. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Yang XD, Xu HT, Xu XH, Ru G, Liu W, Zhu
JJ, Wu YY, Zhao K, Wu Y, Xing CG, et al: Knockdown of long
non-coding RNA HOTAIR inhibits proliferation and invasiveness and
improves radiosensitivity in colorectal cancer. Oncol Rep.
35:479–487. 2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Niu H, Hu Z, Liu H, Hu G, Yang B, Wu S and
Li F: Long non-coding RNA AK027294 involves in the process of
proliferation, migration, and apoptosis of colorectal cancer cells.
Tumor Biol. 37:10097–10105. 2016. View Article : Google Scholar
|
15
|
Li J, Li X, Cen C, Ai X, Lin C and Hu G:
The long non-coding RNA ENST00000547547 reduces 5-fluorouracil
resistance of colorectal cancer cells via competitive binding to
microRNA-31. Oncol Rep. 39:217–226. 2018.PubMed/NCBI
|
16
|
Li H, Wang X, Wen C, Huo Z, Wang W, Zhan
Q, Cheng D, Chen H, Deng X, Peng C, et al: Long noncoding RNA
NORAD, a novel competing endogenous RNA, enhances the
hypoxia-induced epithelial-mesenchymal transition to promote
metastasis in pancreatic cancer. Mol Cancer. 16:1692017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Portt L, Norman G, Clapp C, Greenwood M
and Greenwood MT: Anti-apoptosis and cell survival: A review.
Biochim Biophys Acta. 1813:238–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Punchihewa C, Inoue A, Hishiki A, Fujikawa
Y, Connelly M, Evison B, Shao Y, Heath R, Kuraoka I, Rodrigues P,
et al: Identification of small molecule proliferating cell nuclear
antigen (PCNA) inhibitor that disrupts interactions with PIP-box
proteins and inhibits DNA replication. J Biol Chem.
287:14289–14300. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang SC: PCNA: A silent housekeeper or a
potential therapeutic target? Trends Pharmacol Sci. 35:178–186.
2014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Punt CJ, Koopman M and Vermeulen L: From
tumour heterogeneity to advances in precision treatment of
colorectal cancer. Nat Rev Clin Oncol. 14:235–246. 2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu
K, Yu J and Sung JJ: MicroRNA in colorectal cancer: From benchtop
to bedside. Carcinogenesis. 32:247–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Long Y, Wang X, Youmans DT and Cech TR:
How do lncRNAs regulate transcription? Sci Adv. 3:eaao21102017.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ding J, Lu B, Wang J, Wang J, Shi Y, Lian
Y, Zhu Y, Wang J, Fan Y, Wang Z, et al: Long non-coding RNA
Loc554202 induces apoptosis in colorectal cancer cells via the
caspase cleavage cascades. J Exp Clin Cancer Res. 34:1002015.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Coqueret O: New roles for p21 and p27
cell-cycle inhibitors: A function for each cell compartment? Trends
Cell Biol. 13:65–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Liu Y, Jing Z, Zhang W, Gan J, Hu C, Huang
G and Zhang Y: lncRNA GAS5 enhances G1 cell cycle arrest via
binding to YBX1 to regulate p21 expression in stomach cancer. Sci
Rep. 5:101592015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Cayrol C, Knibiehler M and Ducommun B: p21
binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient
cells. Oncogene. 16:311–320. 1998. View Article : Google Scholar : PubMed/NCBI
|
29
|
Liu L, Zhang H, Shi L, Zhang W, Yuan J,
Chen X, Liu J, Zhang Y and Wang Z: Inhibition of Rac1 activity
induces G1/S phase arrest through the GSK3/cyclin D1 pathway in
human cancer cells. Oncol Rep. 32:1395–1400. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Rosenberg E, Demopoulos RI,
Zeleniuch-Jacquotte A, Yee H, Sorich J, Speyer JL and Newcomb EW:
Expression of cell cycle regulators p57KIP2, cyclin D1,
and cyclin E in epithelial ovarian tumors and survival. Hum Pathol.
32:808–813. 2001. View Article : Google Scholar : PubMed/NCBI
|
31
|
Wang JL, Liu D, Zhang ZJ, Shan S, Han X,
Srinivasula SM, Croce CM, Alnemri ES and Huang Z: Structure-based
discovery of an organic compound that binds Bcl-2 protein and
induces apoptosis of tumor cells. Proc Natl Acad Sci USA.
97:7124–7129. 2000. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Koda M, Przystupa W, Jarzabek K, Wincewicz
A, Kanczuga-Koda L, Tomaszewski J, Sulkowska M, Wolczynski S and
Sulkowski S: Expression of insulin-like growth factor-I receptor,
estrogen receptor alpha, Bcl-2 and Bax proteins in human breast
cancer. Oncol Rep. 14:93–98. 2005.PubMed/NCBI
|
34
|
Kramer N, Walzl A, Unger C, Rosner M,
Krupitza G, Hengstschläger M and Dolznig H: In vitro cell migration
and invasion assays. Mutat Res. 752:10–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Singh A and Settleman J: E MT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
36
|
Li L and Li W: Epithelial-mesenchymal
transition in human cancer: Comprehensive reprogramming of
metabolism, epigenetics, and differentiation. Pharmacol Ther.
150:33–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
37
|
Nalla AK, Estes N, Patel J and Rao JS:
N-cadherin mediates angiogenesis by regulating monocyte
chemoattractant protein-1 expression via PI3K/Akt signaling in
prostate cancer cells. Exp Cell Res. 317:2512–2521. 2011.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Zhang D, Lee H, Haspel JA and Jin Y: Long
noncoding RNA FOXD3-AS1 regulates oxidative stress-induced
apoptosis via sponging microRNA-150. FASEB J. 31:4472–4481. 2017.
View Article : Google Scholar : PubMed/NCBI
|